Form 8-K - Current report:
SEC Accession No. 0001104659-25-102345
Filing Date
2025-10-27
Accepted
2025-10-27 08:35:45
Documents
18
Period of Report
2025-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2529505d1_8k.htm   iXBRL 8-K 34384
2 EXHIBIT 4.1 tm2529505d1_ex4-1.htm EX-4.1 93131
3 EXHIBIT 5.1 tm2529505d1_ex5-1.htm EX-5.1 11245
4 EXHIBIT 10.1 tm2529505d1_ex10-1.htm EX-10.1 53076
5 EXHIBIT 99.1 tm2529505d1_ex99-1.htm EX-99.1 11369
9 GRAPHIC tm2529505d1_ex5-1img001.jpg GRAPHIC 10891
10 GRAPHIC tm2529505d1_ex5-1img002.jpg GRAPHIC 5663
  Complete submission text file 0001104659-25-102345.txt   442628

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA sls-20251024.xsd EX-101.SCH 3041
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE sls-20251024_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sls-20251024_pre.xml EX-101.PRE 22377
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2529505d1_8k_htm.xml XML 3688
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 251417619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)